... as many as 300,000 COVID-19 cases around the world can be traced to a two-day biotech meeting at a hotel in downtown Boston last February.
News
- The Latest: Study: 2-drug treatment helpful for coronavirus
- Tiny Biotechs Extend Wild Rides as Day Traders Chase Booms
... for the next tiny biotech stock to gamble on. Sellas is set to present data on Friday at the San Antonio Breast Cancer Symposium -- the same meeting ...
- 84 Biggest Movers From Yesterday
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to ... was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 26% to close at $5.43.
- Stock Alert: SELLAS Life Sciences Hits New 52-week High
Stock Alert: SELLAS Life Sciences Hits New 52-week High ... (RTTNews) - Shares of biopharmaceutical company SELLAS Life Sciences Group, Inc. ... at the 2020 San Antonio Breast Cancer Symposium on Friday, December 11.
- Grenwich Shares Skyrocket 2300% After Firm Presents 5-Year Clinical Breast Cancer Trial Data ...
... of a poster for the GP2 Phase 2b clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.".